Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
18.61
-0.16 (-0.85%)
At close: May 12, 2025, 4:00 PM
18.63
+0.02 (0.11%)
After-hours: May 12, 2025, 7:26 PM EDT
Rigel Pharmaceuticals Market Cap
Rigel Pharmaceuticals has a market cap or net worth of $332.61 million as of May 12, 2025. Its market cap has increased by 68.58% in one year.
Market Cap
332.61M
Enterprise Value
356.55M
1-Year Change
68.58%
Ranking
Category
Stock Price
$18.61
Market Cap Chart
Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $332.61M, an increase of 30.48%. That is a compound annual growth rate of 1.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 335.50M | 13.23% |
| Dec 31, 2024 | 296.30M | 17.21% |
| Dec 29, 2023 | 252.80M | -2.51% |
| Dec 30, 2022 | 259.30M | -42.78% |
| Dec 31, 2021 | 453.20M | -23.37% |
| Dec 31, 2020 | 591.40M | 64.87% |
| Dec 31, 2019 | 358.70M | -6.42% |
| Dec 31, 2018 | 383.30M | -32.57% |
| Dec 29, 2017 | 568.40M | 141.36% |
| Dec 30, 2016 | 235.50M | -12.19% |
| Dec 31, 2015 | 268.20M | 34.57% |
| Dec 31, 2014 | 199.30M | -20.02% |
| Dec 31, 2013 | 249.20M | -55.93% |
| Dec 31, 2012 | 565.50M | 0.60% |
| Dec 30, 2011 | 562.10M | 43.14% |
| Dec 31, 2010 | 392.70M | -20.31% |
| Dec 31, 2009 | 492.80M | 68.36% |
| Dec 31, 2008 | 292.70M | -62.86% |
| Dec 31, 2007 | 788.20M | 164.67% |
| Dec 29, 2006 | 297.80M | 47.43% |
| Dec 30, 2005 | 202.00M | -57.71% |
| Dec 31, 2004 | 477.70M | 68.26% |
| Dec 31, 2003 | 283.90M | 465.54% |
| Dec 31, 2002 | 50.20M | -71.28% |
| Dec 31, 2001 | 174.80M | -51.24% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |